A carregar...
Publicação
Sexual function and disease progression in women with advanced cancer
| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 439.77 KB | Adobe PDF |
Orientador(es)
Resumo(s)
Purpose: To prospectively evaluate sexual function, body image, quality of life, and disease
progression rates in women with advanced cancer.
Methods: Sixty women staged III–IV breast, gynaecological, or colorectal cancer completed the
Female Sexual Function Index (FSFI), the Body Image Scale, the European Organisation for
Research and Treatment of Cancer Quality of Life Questionnaire (EORTQL), and the Beck
Depression Inventory. Forty-three women (71.67%) completed the questionnaires again
approximately 1 year later. The Wilcoxon test was used to compare the scores between the two
evaluations. The participants were informed that they could attend additional consultations for
symptom control or management of sexual difficulties if they wished.
Results: Twenty-eight women showed disease progression (65.12%), and seven died. Twenty one women remained sexually active (48.8%), all of whom were married/partnered. There was
no difference in the FSFI score over time [28 (21.4–32.1) vs. 30.3 (24.2–33.3) P = 0.19]. The body
image scores improved [6 (1–15) vs. 3 (0–10), P = 0.039], while the perceived global health status
worsened [EORTQL: 75 (50–83.3) vs. 41.7 (25–50), P = 0.001].
Conclusions: Body image scores improved over time despite a concomitant decrease in the
perceived global health status. A portion of women with recurrent or metastatic cancer
remained interested in sexual intimacy. New studies are needed to understand the differences
between the needs of women with advanced cancer who are vs. are not sexually active, for the
development of more effective therapeutic approaches.
Descrição
Palavras-chave
Sexual Function; Cancer; Advanced Cancer; Female Sexuality; Body image; Quality of life
Contexto Educativo
Citação
Campos, L.S., De Nardi, S.P., Limberger, L.F. et al. Sexual function and disease progression in women with advanced cancer. Support Care Cancer 30, 5093–5098 (2022). https://doi.org/10.1007/s00520-022-06797-x